Involvement of cell and serum proteases in exposing tumor-specific agglutinin sites.
D000371:Agglutination / Q000187:drug effects*; D000373:Agglutinins; D000818:Animals; D000912:Antibodies, Neoplasm; D001666:Binding Sites, Antibody; D002462:Cell Membrane / Q000276:immunology; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D002642:Chick Embryo; D003260:Contact Inhibition / Q000187:drug effects; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005347:Fibroblasts; D051379:Mice; D010447:Peptide Hydrolases / Q000494:pharmacology*; D014361:Trypsin Inhibitors / Q000494:pharmacology
D000373:Agglutinins; D000912:Antibodies, Neoplasm; D004273:DNA, Neoplasm; D014361:Trypsin Inhibitors; D010447:Peptide Hydrolases